Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.

about

Current applications of biomarkers in cardiomyopathies.Systemic amyloidosis: novel therapies and role of biomarkers.New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.

P2860

Q38536678-973A7720-FE7B-447C-94BB-0A69E2831C0E Q38829923-FE5E89FF-869F-46B1-932F-07881309BDF4 Q39024208-4346163C-7F56-4416-861D-8C4876471FC0

P2860

Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.

Item

http://www.wikidata.org/entity/Q44657473

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Osteopontin: a novel predictor ...... temic light-chain amyloidosis.

@en

Osteopontin: a novel predictor ...... temic light-chain amyloidosis.

@nl

type

Item

label

Osteopontin: a novel predictor ...... temic light-chain amyloidosis.

@en

Osteopontin: a novel predictor ...... temic light-chain amyloidosis.

@nl

prefLabel

Osteopontin: a novel predictor ...... temic light-chain amyloidosis.

@en

Osteopontin: a novel predictor ...... temic light-chain amyloidosis.

@nl

P1476

Osteopontin: a novel predictor ...... temic light-chain amyloidosis.

@en

P2093

Arnt V Kristen

http://www.w3.org/2001/XMLSchema#string

Corina Merkle

http://www.w3.org/2001/XMLSchema#string

David Lindenmaier

http://www.w3.org/2001/XMLSchema#string

Evangelos Giannitsis

http://www.w3.org/2001/XMLSchema#string

Florian Andre

http://www.w3.org/2001/XMLSchema#string

Henning Steen

http://www.w3.org/2001/XMLSchema#string

Hugo A Katus

http://www.w3.org/2001/XMLSchema#string

Mark Rosenberg

http://www.w3.org/2001/XMLSchema#string

Norbert Frey

http://www.w3.org/2001/XMLSchema#string

Philipp A Schnabel

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Myocardial osteopontin expression coincides with the development of heart failure.

An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Current trends in diagnosis and management of cardiac amyloidosis.

A practical approach to the echocardiographic evaluation of diastolic function.

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Osteopontin: a bridge between bone and blood.

P304

202-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13506129.2014.940457

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Röcken

Stefan Schönland

P577

2014-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25007036

http://www.w3.org/2001/XMLSchema#string

Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.

about

P2860

P2860

Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698